SomnoMed Ltd (OTCPK:SOMNF)

Full Year 2025 Somnomed Ltd Earnings Call Transcript

Aug 27, 2025 / 01:00 AM GMT

Release Date Price: $0.4361

Transcript

Key Points

Positve

SomnoMed Ltd (SOMNF) achieved a 22% year-on-year revenue growth, reaching $111.5 million, surpassing their guidance of $105 million.
The company reported a significant turnaround in EBITDA, increasing to $9.2 million from $0.6 million in FY24.
Positive operating cash flow of $4.8 million was achieved, compared to a negative $8.9 million in the previous year.
SomnoMed Ltd (SOMNF) successfully cleared its backlog, improving turnaround times and enhancing customer service levels.
The company received FDA clearance for its Rest Assure product, marking a significant advancement in compliance monitoring technology.

Negative

Despite the positive financial performance, the company anticipates growth to return to more sustainable levels in FY26.
There was a moderation in demand in the APAC region following a price increase in Q4.
The company is still exploring the possibility of opening a second manufacturing site, indicating potential capacity constraints in the future.
Lease liabilities increased due to the renewal of existing leases and investments in manufacturing expansion.
The company faces market shifts in the United States, which could impact growth projections.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SOM.AX - SomnoMed Ltd
Full Year 2025 Somnomed Ltd Earnings Call
Aug 28, 2025 / 01:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Recording in.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning everybody and welcome to the Somommet results presentation for FY25. With us this morning, we have co-CEOs E Maria Blixit and Karen Borg and CFO Yefei Wo, who will take us through the presentation that was lodged with the ASX, earlier today. Just a bit of housekeeping before we kick off.

Webinar is being recorded, including the Q&A, and we will post this on Sondommet's website following the completion of the webinar.

We invite research analysts to ask questions at the end of the presentation.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.